About Us

Our Philosophy & Vision

At QuikPath we are dedicated to removing the complexity and anxiety from diagnostic testing. Through our ‘Plug and Play’ platform, we strive to bring infectious disease testing closer to the end-user through molecular testing technologies that are accurate, accessible, and affordable diagnostic test kits that can be used by anyone, anywhere.

The problem of lab-based diagnostic testing

Infectious disease testing is time-consuming, requires highly skilled professionals and the cost of the Covid-19 test in Singapore is expensive – often resulting in delays in diagnosis and treatment. The lack of portability of current tests further limits access to diagnostics.

TURNAROUND TIME

Turnaround times ranging up to one week
.

LOGISTICS

Long sample transportation times
.

EFFORT & SKILL

Lab-based testing requires scientific equipment and trained professionals

HIGH COST

Lab-based testing is very expensive
.

DELAYED TREATMENT & GREATER SPREAD OF DISEASE!

QuikPath’s Solution for COVID-19 Diagnostic Testing

The first of its kind, truly point-of-care test for infectious disease testing, QuikPath’s unique accurate, accessible, and affordable diagnostic kits eliminate the complexity of the diagnostic testing process while enabling increased access and reducing the overall burden and cost of the COVID-19 test in Singapore. Our first product, QScreen for COVID-19 diagnostic testing, addresses the need of the hour – the ongoing SARS-CoV-2 pandemic.

FAST TURNAROUND TIME

Accurate results in 40 minutes!

PORTABILITY

Simplified workflow allows tests to be performed anywhere

EASY TO USE

Does not require scientific equipment or trained professionals

LOW CAPEX

Affordably priced to encourage wide-spread testing

Innovation and Technology in Molecular Testing

“Plug and Play” platform with integrated sample processing,
proprietary biology, and robust partner ecosystem.

CARTRIDGE

cartridge-white

Microfluidic design with integrated sample processing. IP owned by QP (patent pending)

BIOLOGY

partners-icon

Proprietary expandable platform with specificity 100%, sensitivity >95%

PARTNER ECOSYTEM

partners-icon

Supported by robust start-up and corporate ecosystem in Singapore

Icon

OUR TEAM

We are a team of exceptionally talented and driven entrepreneurs and professionals with expertise ranging from R&D to commercialization, from design to manufacturing, from marketing to quality assurance and regulatory affairs. Together, we share a common passion for increasing access to COVID-19 diagnostic testing through accurate, accessible, and affordable diagnostics and molecular testing technology.

Our Investors and Partners

0B USD
Burden of Inadequate Testing
0B USD
Market Size of POC Testing
0%
CAGR of POC Testing Market